As of Jul 22
| -0.10 / -0.99%|
The 8 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 23.50, with a high estimate of 39.00 and a low estimate of 17.00. The median estimate represents a +134.06% increase from the last price of 10.04.
The current consensus among 9 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.